Breaking Finance News

Stifel Nicolaus disclosed Quintiles IMS Holdings Inc (NYSE:Q), hiking its price target to $84.00 earlier today

Stifel Nicolaus bumped up the target of Quintiles IMS Holdings Inc (NYSE:Q) to $84.00 stating a potential upside of 0.11%.

Boasting a price of $75.80, Quintiles IMS Holdings Inc (NYSE:Q) traded 0.00% even on the day. With the last stock price close up 5.67% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Quintiles IMS Holdings Inc has recorded a 50-day average of $78.02 and a two hundred day average of $71.64. Volume of trade was down over the average, with 0 shares of Q changing hands under the typical 1,100,820

Performance Chart

Quintiles IMS Holdings Inc (NYSE:Q)

With a total market value of $0, Quintiles IMS Holdings Inc has price-earnings ratio of 22.76 with a one year low of $55.01 and a one year high of $81.45 .

A total of 15 equity analysts have released a research note on Q. Eight equity analysts rating the company a strong buy, nine firms rating the stock a buy, 2 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell with a consensus target price of $76.50.

General Company Details For Quintiles IMS Holdings Inc (NYSE:Q)

Quintiles IMS Holdings Inc, formerly Quintiles Transnational Holdings Inc., is a provider of biopharmaceutical development services and commercial outsourcing services. It is engaged in the development and commercialization of pharmaceutical therapies. Its segments include Product Development and Integrated Healthcare Services. Its Product Development segment is a contract research organization and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. The Integrated Healthcare Services segment includes commercial pharmaceutical sales and service organizations, and provides services, including commercial services, such as contract pharmaceutical sales forces, and healthcare business services for the healthcare sector, such as phase research, market access and consulting, health information analytics and technology consulting, and other healthcare solutions.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *